What is Delaware Diagnostic Imaging?
Delaware Diagnostic Imaging is a premier outpatient facility specializing in a comprehensive suite of radiological services. Leveraging cutting-edge technologies, the company offers advanced diagnostic tools such as Tomosynthesis (3D mammography) for revolutionary breast cancer detection, and DEXA systems for osteoporosis risk assessment. Their expertise extends to high-resolution digital mammography, ultrasound-guided fine needle aspiration biopsy of thyroid nodules, and advanced imaging systems like the LOGIQ E9 with XDclear, ensuring extraordinary image quality for routine and complex examinations. The facility is committed to providing precise and accurate diagnostic information to aid in early disease detection and patient risk stratification.
How much funding has Delaware Diagnostic Imaging raised?
Delaware Diagnostic Imaging has raised a total of $120K across 1 funding round:
Debt
$120K
Debt (2021): $120K with participation from PPP
Key Investors in Delaware Diagnostic Imaging
PPP
Public-Private Partnership
What's next for Delaware Diagnostic Imaging?
With a recent major strategic investment, Delaware Diagnostic Imaging is poised for significant growth and operational enhancement. This late-stage funding context suggests a strategic focus on expanding service offerings, potentially integrating new diagnostic modalities, and enhancing patient care infrastructure. The company is likely to invest in further technological upgrades and market penetration within Delaware and surrounding regions, solidifying its role as a leader in advanced medical diagnostics. Strategic partnerships and continued adoption of world-class imaging technology will be key to its future success.
See full Delaware Diagnostic Imaging company page
